General Policies

• Abstracts submitted must contain original work that has not been published or submitted for presentation at any national or international meeting prior to the 21st World Congress on In Vitro Fertilization (ISIVF2023) .
• Abstracts must be submitted in English.
• Abstracts will be considered for oral presentation, unless authors specify "Poster Only" on the submission form. Abstracts not selected for oral presentation will be considered for poster presentation.
• Notifications regarding acceptance/rejection will be emailed to the authors from September 8, 2023.
• Authors presenting abstracts must be registered participants. Presenters that fail to complete their registration by September 14, 2023 will not be included in the Final Program.
• All decisions by the Scientific Committee are final. Dates and times of presentations cannot be changed.
• Only abstracts submitted via the online submission system will be accepted; abstracts submitted by fax, post or email will be ignored.

Abstract Submission

Please note that following steps are required.

1. Register personal information from ‘New Registration’ button at (https://secure101.jtbcom.co.jp/isivf_jsar2023/Default.aspx).
2. Submit abstract by ‘Abstract Submission: ISIVF’ button after personal information registration is completed.

Please note that authors will receive each confirmation e-mails when personal information registration and abstract submission is completed. If you do not receive confirmation, your registration/submission may not have been received and you are advised to contact the organizer.

Upon receiving personal information, ‘Registration Number’ will be issued. And ‘Abstract No.’ will be issued after the submission.

To view, edit, or delete your submitted abstract, please log in to the abstract submission site from above button.
(Registered e-mail address and "Password" will be required to log in the page.)

Abstract Categories

1. ART, Clinical
2. ART, Basic Research
3. ART, Laboratory
4. Contraception
5. Counselling, Ethics and Psychosocial
6. Embryology
7. Endocrinology, Clinical
8. Endocrinology, Laboratory
9. Female Infertility
10. Fertility Preservation
11. Gynaecology and Surgery
12. Male Fertility
13. Menopause
14. Nursing
15. Ovary and Ovarian Biology
16. PCOS
17. Preimplantation Screening and Diagnosis
18. Regenerative Medicine and Stem Cells
19. Reproductive Genetics
20. Uterine Disorders and Endometriosis

Abstract Content & Format　

1. Abstracts must describe the research performed. Only abstracts with the following headings can be considered. Failure to follow this format will disqualify the abstract.
   • Introduction: (should be informative and short, stating why the study was conducted)
   • Material & Methods: (indicating the locale, number and type of human subjects, non-human species or material being studied, the principal procedures, assays, test or treatments performed)
   • Results: (confirming or refuting the hypothesis, supported by statistics if appropriate)
   • Conclusions: (stating the major new findings of the study and specifying what these findings add to what is known already)
2. The use of graphs, tables and images is strongly discouraged.
3. Do not identify individuals in the title or abstract body.
4. Invited speakers are required to submit your brief biography and portrait photo on the abstract submission system.
5. Please note that there is limit on the number of institutions, co-authors, abstract title, abstract body and brief biography as follows:
   • Institution: up to 6
   • Co-authors: up to 10
   • Abstract title: up to 200 characters
   • Abstract body (for Oral/Poster presentation): up to 2,500 characters
   • Abstract body (for invited speakers): up to 3,500 characters
   • Brief biography (Invited speakers only): up to 1,000 characters
6. Acceptable file format for the image is JPEG (.jpg) and GIF (.gif).

Oral & Poster Presentation

Abstracts will be considered for oral presentation, unless authors specify "Poster Only" on the submission form.

Abstracts not selected for oral presentation will be considered for poster presentation.

1. Oral presentations will be 7 minutes in length followed by 3 minutes of discussion. Only PowerPoint will be supported.
2. Surface areas of the poster boards are 180 cm high x 90 cm wide.

Awards

Awards for the best oral presentation and best poster presentation will be granted for outstanding research works.